EMBECTA CORP. Pension Expense (Reversal of Expense), Noncash
EMBECTA CORP. (EMBC) reported Pension Expense (Reversal of Expense), Noncash of $6.40 million for the 9-month period ending 2022-06-30, per its 10-Q filed 2022-08-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:PensionExpenseReversalOfExpenseNoncash · last filed 2022-08-15
- EMBECTA CORP. pension expense (reversal of expense), noncash for the quarter ending 2022-06-30 was $2.80M, a 33.33% increase year-over-year.
- EMBECTA CORP. pension expense (reversal of expense), noncash for the quarter ending 2022-03-31 was $1.40M, a 44.00% decline year-over-year.
- EMBECTA CORP. pension expense (reversal of expense), noncash for the quarter ending 2021-12-31 was $2.20M, a 8.33% decline year-over-year.
- EMBECTA CORP. pension expense (reversal of expense), noncash for the quarter ending 2021-06-30 was $2.10M.
| Period end | Pension Expense (Reversal of Expense), Noncash 3 month | Pension Expense (Reversal of Expense), Noncash 6 month | Pension Expense (Reversal of Expense), Noncash 9 month |
|---|---|---|---|
| 2022-06-30 | $2.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-15 | $4.20M derived: sum of 2 quarters · filed 2022-08-15 | $6.40M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $1.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-13 | $3.60M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $2.20M 10-Q · filed 2022-03-16 | ||
| 2021-06-30 | $2.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-15 | $4.60M derived: sum of 2 quarters · filed 2022-08-15 | $7.00M 10-Q · filed 2022-08-15 |
| 2021-03-31 | $2.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-13 | $4.90M 10-Q · filed 2022-05-13 | |
| 2020-12-31 | $2.40M 10-Q · filed 2022-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |